FDA product code · Clinical toxicology

Radioimmunoassay, Digoxin (3-H), Rabbit Antibody, Coated Tubes Sep.

Name: FDA decisions, review times, recalls and adverse event reports for product code DNQ
Creator: 510(k) Report

DNQClass II21 CFR 862.3320510(k) required0 decisions0 recalls

0 FDA decisions. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical toxicology panel

Twenty years of DNQ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · DNQ

FDA has decided no DNQ device since 2007.

Median 510(k) review, days · DNQ

Too few DNQ 510(k)s in any year since 2007 to give a median.

Recalls per year · DNQ

No recall names DNQ since 2007.

Adverse event reports per year · DNQ

1in 2025

2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code DNQ, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	0
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	1
2026	—	—

FIG. 1 — DNQ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in DNQ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 862.3320.